Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Can Ingham’s Deliver?

Dec 21 2016

Brokers are crowing about newly listed poultry producer, Ingham’s Group, but concede there are risks investors should be wary of.


Brokers Approve Crown Resorts Restructure

Dec 20 2016

Amid a soft trading update, casino property operator Crown Resorts has outlined initiatives to simplify its business and enhance the balance sheet.


Independence Group: Focus Shifts To Nickel

Dec 19 2016

Independence Group has released an interim report from its Long Island study, which should de-risk the Tropicana project. The focus is expected to return to the upside potential at Nova.


Uncertainty Over Woolworths Fuel Dogs Caltex

Dec 16 2016

Caltex has provided 2016 profit guidance, prompting some brokers to review their numbers, but uncertainty remains linked to the Woolworths fuel business.


Consolidation Outdoors

Dec 15 2016

APN Outdoor ((APO)) and oOh!media ((OML)) have proposed a merger which, if successful, would produce a substantial, diversified outdoor media grouping.


NextDC Sell-Off Unwarranted

Dec 14 2016

Data centre operator NextDC has been sold off sharply but brokers believe the company’s position has been greatly misunderstood.


Iluka Raises Rutile Profile, But Will It Pay?

Dec 14 2016

Mineral sands producer Iluka Resources has raised its profile in global rutile production. Brokers emphasise higher prices are required to make the acquisition pay.


Estia Health Beset By Uncertainty

Dec 13 2016

Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.


Brokers Question IAG’s Change In Tack

Dec 13 2016

Insurance Australia Group’s is shift to a more customer-centric model has brokers highlighting the risks.


Sirtex Reaction Overdone

Dec 12 2016

Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.



Analyse The Market From A Different Angle